Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Severe inherited retinal diseases

Our research has initially focused on solutions for severe inherited retinal diseases. In the longer term, we hope to find solutions for patients faced with neurodegenerative diseases more generally.
Direct access
  • Diseases we target
  • Leber's Hereditary Optic Neuropathy
  • Retinitis pigmentosa (RP)
  • Geographic atrophy in dry AMD
  • Home >
  • Diseases

 

 

  • Diseases we target
  • Leber Hereditary Optic Neuropathy (LHON)
  • Retinitis Pigmentosa (RP)
  • Geographic Atrophy in Dry-AMD
© 2024 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page